Clinical Trials Browser

Phase 1 × Uveal Melanoma × MART-1 Antigen × Clear all

NCT00005841 2014-05-22

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1 Terminated

Uveal Melanoma, Melanoma

NCT00025181 2014-05-22

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Phase 1 Completed

Uveal Melanoma, Melanoma